Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H26N6 |
InChIKeyKTNNFJWKVZAKSX-UHFFFAOYSA-N |
CAS Registry3036492-84-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | IT | 07 Apr 2023 |